119 results
Page 3 of 6
8-K
EX-1.1
fy2l3gsfcm
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
424B5
esdew
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-10.3
bh4yaezivw q3n762jkg
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
g2ie0rp
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.2
aedx57ormpg
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
9uht imjgexd6gtf
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-10.1
d6o6 mmtjounrp
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
gmhv57hfz2207
26 Jun 20
Registration of securities for employees
5:01pm
8-K
EX-1.1
5tfwxg 9yfrs4iup
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
fki0tm
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
6qazsfcui
23 Jun 20
Prospectus supplement for primary offering
4:06pm